Glycyrrhetinic acid alleviates atrial fibrillation by inhibiting the expression of PIM1
Chemical Biology and Drug Design
FEBRUARY 6, 2024
By dint of a relatively high content of glycyrrhetinic acid (GA), radix glycyrrhizae preparata is often adopted to treat atrial fibrillation (AF). Thus, the mechanism of GA was expounded in our study. Our research concludes that GA alleviates AF through suppressing the expression of PIM1. Abstract Glycyrrhetinic acid (GA) is known to exert a cardioprotective effect, while its mechanism in atrial fibrillation (AF) remains poorly defined.
Let's personalize your content